SCHEMBL3205558

SCHEMBL3205558

CCC(CC)c1cc(Cl)c(OC)c2nc(Oc3ccc(Cl)cc3S(N)(=O)=O)n(C)c12

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 6/20 0.48
PTGES2 Q9H7Z7 2/20 0.36
LMNA P02545 1/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
POLB P06746 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
RAB9A P51151 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
TP53 P04637 1/20 0.34
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
WDR5 P61964 1/20 0.33
TSHR P16473 1/20 0.33
KAT6A Q92794 1/20 0.33
BRD4 O60885 1/20 0.33
ALPL P05186 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14198165 0.90 CRHR1 (0.47) CRHR1LMNAHTTNPSR1POLB
SCHEMBL3207756 0.89 CRHR1 (0.48) CRHR1PTGES2LMNAHTTNPSR1
SCHEMBL13423132 0.81 CRHR1 (0.46) CRHR1PTGES2
SCHEMBL3211954 0.78 CRHR1 (0.72) CRHR1
SCHEMBL2056029 0.74 CRHR1 (0.53) CRHR1LMNAPOLBKDM4EALDH1A1
SCHEMBL13423135 0.73 CRHR1 (0.53) CRHR1PTGES2LMNAHTTNPSR1
SCHEMBL2055982 0.72 CRHR1 (0.70) CRHR1HTTALDH1A1HPGDL3MBTL1
SCHEMBL2056017 0.72 CRHR1 (0.63) CRHR1LMNAKDM4EALDH1A1RAB9A
SCHEMBL2056027 0.72 CRHR1 (0.81) CRHR1LMNAHTTNPSR1POLB
SCHEMBL2056030 0.71 CRHR1 (0.51) CRHR1LMNAHTTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118459363-B Fluorine substituted proliferation cell nuclear antigen inhibitor and preparation method and application thereof 安徽贝克制药股份有限公司 2024-12-17 CN claimed
CN-118546074-A Deuterated proliferation cell nuclear antigen inhibitor and preparation method and application thereof 安徽贝克制药股份有限公司 2024-08-27 CN claimed
CN-118459363-A Fluorine substituted proliferation cell nuclear antigen inhibitor and preparation method and application thereof 安徽贝克制药股份有限公司 2024-08-09 CN claimed
CN-118459363-B Fluorine substituted proliferation cell nuclear antigen inhibitor and preparation method and application thereof 安徽贝克制药股份有限公司 2024-12-17 CN disclosed
CN-118546074-A Deuterated proliferation cell nuclear antigen inhibitor and preparation method and application thereof 安徽贝克制药股份有限公司 2024-08-27 CN disclosed
CN-118459363-A Fluorine substituted proliferation cell nuclear antigen inhibitor and preparation method and application thereof 安徽贝克制药股份有限公司 2024-08-09 CN disclosed
EP-1369221-B9 SUCCESSIVELY BIAXIAL-ORIENTED POROUS POLYPROPYLENE FILM AND PROCESS FOR PRODUCTION THEREOF NEW JAPAN CHEM CO LTD (JP) 2010-12-29 EP disclosed
US-7682689-B2 A polypropylene-based resin and a beta-crystal nucleating agent having a film thickness uniformity of < 0.1 and the film exhibiting good stability; high air-permeability and porosity; good feeling and electrical resistance required for a battery separator; industrial scale; NEW JAPAN CHEMICAL CO., LTD. (JP) 2010-03-23 US disclosed
US-20100056515-A1 BENZIMIDAZOLE COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-03-04 US disclosed
EP-1369221-B1 SUCCESSIVELY BIAXIAL-ORIENTED POROUS POLYPROPYLENE FILM AND PROCESS FOR PRODUCTION THEREOF NEW JAPAN CHEM CO LTD (JP) 2009-11-11 EP disclosed
EP-2088861-A2 BENZIMIDAZOLE COMPOUNDS Takeda Pharmaceutical Company Limited (JP) 2009-08-19 EP disclosed
WO-2008051533-A2 BENZIMIDAZOLE COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-05-02 WO disclosed
US-20070269719-A1 A polypropylene-based resin and a beta-crystal nucleating agent having a film thickness uniformity of < 0.1 and the film exhibiting good stability; high air-permeability and porosity; good feeling and electrical resistance required for a battery separator; industrial scale; NEW JAPAN CHEMICAL CO., LTD. (JP) 2007-11-22 US disclosed
US-7235203-B2 Successively biaxial-oriented porous polypropylene film and process for production thereof NEW JAPAN CHEMICAL CO., LTD. (JP) 2007-06-26 US disclosed
US-20040096744-A1 Extrusion from melt, stretching; mixture of polypropylene and nucleation NEW JAPAN CHEMCIAL CO., LTD. (JP) 2004-05-20 US disclosed
EP-1369221-A1 SUCCESSIVELY BIAXIAL-ORIENTED POROUS POLYPROPYLENE FILM AND PROCESS FOR PRODUCTION THEREOF NEW JAPAN CHEMICAL CO.,LTD. (JP) 2003-12-10 EP disclosed
EP-0251784-A2 Naphthalenylsulfonylimidazolidinediones and their thioxo analogs AMERICAN HOME PRODUCTS CORPORATION (US) 1988-01-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056515-A1 BENZIMIDAZOLE COMPOUNDS HRH4, SSTR5, CNR1 CRHR1 4/4885PTGES2 3390/4885LMNA 4357/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.